The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer - Test2 - elhamkhani - TriplyDB

The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer

The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer

http://www.wikidata.org/entity/Q21195217

about

Usp18 regulates epidermal growth factor (EGF) receptor expression and cancer cell survival via microRNA-7.Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy.Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) as a prognostic marker for local control in T1-2 N0 breast cancer treated with breast-conserving surgery and radiation therapy (BCS + RT).Interferon-β signaling contributes to Ras transformation Gene expression changes in initiation and progression of oral squamous cell carcinomas revealed by laser microdissection and oligonucleotide microarray analysis.The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective.Reduced DICER1 elicits an interferon response in endometrial cancer cells The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapy.Krüppel-like factor 9 (KLF9) prevents colorectal cancer through inhibition of interferon-related signaling.Prognostic value of ISG15 mRNA level in drinkers with esophageal squamous cell cancers.ISG15 as a novel prognostic biomarker for hepatitis B virus-related hepatocellular carcinoma.Rac-specific guanine nucleotide exchange factor DOCK1 is a critical regulator of HER2-mediated breast cancer metastasis.ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinoma Positive feedback regulation of p53 transactivity by DNA damage-induced ISG15 modification.ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system.Interferon-stimulated gene 15 in hepatitis B-related liver diseases.Interferon-stimulated gene 15 and the protein ISGylation system.Type I interferon responses are impaired in latently HIV infected cells.Deregulation of Interferon Signaling in Malignant Cells.ISGylation governs the oncogenic function of Ki-Ras in breast cancer.ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells.G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer.Expression, regulation and function of the ISGylation system in prostate cancer.Oncogene-mediated regulation of p53 ISGylation and functions.Cell type-dependent regulation of free ISG15 levels and ISGylation.Identification of differentially expressed genes in the development of osteosarcoma using RNA-seq.ISG15: A double edged sword in cancer.SUMOylation of the ING1b tumor suppressor regulates gene transcription.ISG15 silencing increases cisplatin resistance via activating p53-mediated cell DNA repair.Regulation of mitophagy by the ubiquitin pathway in neurodegenerative diseases.miR-2909 regulates ISGylation system via STAT1 signalling through negative regulation of SOCS3 in prostate cancer.Analysis of Brca1-deficient mouse mammary glands reveals reciprocal regulation of Brca1 and c-kit.Overexpression of MMP13 is associated with clinical outcomes and poor prognosis in oral squamous cell carcinoma

P2860

Q30425986-C5772D6C-2368-46C3-8895-DB4699FF4807 Q31108673-0F6013E6-4464-469D-A556-AF146B48C7D6 Q33633839-D343A815-922A-4CAF-960E-B37D130D84B2 Q33924893-A5A632B4-9242-4546-8A38-745F6C823018 Q34012857-07540DBE-3704-417F-9F52-761BD68EA3C5 Q34284620-C9F89F47-8310-4426-A7FD-E832ADDB3AB6 Q35572396-47F11458-E9A7-4384-AF3F-1C2E194C90E2 Q35740189-6CB2410D-ABE1-4C8B-8537-BF5B773E5187 Q35840362-5C46EA4B-33D9-46B9-8B1C-D41E98792D29 Q36032635-67B8C711-87C4-487F-93E2-9A406D0D44F7 Q36069877-3B7B9C25-3752-4D8B-8ABC-62A220E5B508 Q36261580-63D0320C-1FE5-4069-B139-02F964F90D32 Q36411445-2D53678C-4921-4985-A06C-3F8EF873926A Q36820193-271BB9D1-307E-403E-8EA9-8203A116FF83 Q37086155-FDE7F457-B57F-4994-88B6-0FB32B213AF2 Q37201724-532791B7-FC4B-42A0-9B30-2F67C3612823 Q37687572-06ACC2EA-801F-4779-B6FA-7DCEEA28FEDA Q37708705-EE9335CF-07C3-43E5-976B-D7FF22EEAA7C Q37824472-B267973C-7BDE-45EF-AB67-9028BF966129 Q38747126-6F051430-E17E-4B05-91DF-A3D31BA096DE Q38974179-24640E69-A85F-44D2-8E8C-6175CCA1C08A Q39210782-F09DC46A-4FF9-4E8E-A93E-5E74DB05D7A3 Q39425033-EF337C9A-DEE8-4D7C-AEB7-2F8AA73CDB57 Q39458594-26117044-3B6B-411D-9E97-9893A244160D Q39853440-64D7F772-4FCA-408E-AB7E-2C4DCDAA9B55 Q41836912-7850BD39-8D1F-4B3E-A54A-A45BD9B893DD Q41865133-2C7799AB-B57D-4841-BCDE-D7C21B848893 Q41960320-88696010-4A70-4B9A-BB47-B33DA8B6B935 Q42038867-ABB44ED3-414A-4F8F-95F4-1977DEEE2194 Q42920096-75729EB4-3A5F-4542-BA1A-9EAC30185B7F Q47138566-90303BE5-34DC-4C66-A6E2-BD72DA1EFE00 Q47216699-84607BC9-B4B4-473C-9020-011777442AB6 Q48264888-F9E9D162-0A3B-4BE2-8BAD-DDA81A85828F Q52605706-7836D8F8-4D4D-4F55-9D04-4B52B002BC4D Q59101042-208B1522-1B65-4B2E-981F-B3B707CAF8CF

P2860

The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer

http://www.wikidata.org/entity/Q21195217

description

2008 nî lūn-bûn

@nan

2008 թուականին հրատարակուած գիտական յօդուած

@hyw

2008 թվականին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

name

The ubiquitin-like molecule in ...... marker in human breast cancer

@ast

The ubiquitin-like molecule in ...... marker in human breast cancer

@en

The ubiquitin-like molecule in ...... marker in human breast cancer

@en-gb

The ubiquitin-like molecule in ...... marker in human breast cancer

@nl

type

label

The ubiquitin-like molecule in ...... marker in human breast cancer

@ast

The ubiquitin-like molecule in ...... marker in human breast cancer

@en

The ubiquitin-like molecule in ...... marker in human breast cancer

@en-gb

The ubiquitin-like molecule in ...... marker in human breast cancer

@nl

prefLabel

The ubiquitin-like molecule in ...... marker in human breast cancer

@ast

The ubiquitin-like molecule in ...... marker in human breast cancer

@en

The ubiquitin-like molecule in ...... marker in human breast cancer

@en-gb

The ubiquitin-like molecule in ...... marker in human breast cancer

@nl

P1433

Q21195217-14A8FB9D-F553-4FB3-A6D9-C08F1E5FDE07

P1476

Q21195217-8959AE24-6209-465B-B82D-5A8ABD7ABE7E

P2093

Q21195217-055E3539-9F78-4CAB-9B4F-7E58532579C4

Q21195217-23D4FF04-01AB-4605-B198-D963E9B33C07

Q21195217-3AB26F31-F0E4-4D0A-9E2B-04196E7FBEAF

Q21195217-61BBA668-362B-43AD-B47B-8517233191CD

Q21195217-78B3028D-7CA3-4F4B-A23F-3B12CB3E5DEE

Q21195217-C14C76C6-62A9-4CD5-AFC7-099633DA6A29

Q21195217-CE23CC45-9E07-4E0D-A74C-F6F0313B2CC4

P2860

Q21195217-1952BAB9-1B34-4E57-80EB-5FA56C9BB68B

Q21195217-36190DA8-2661-406E-8555-07B99C415304

Q21195217-46ECCCF3-14B9-4F8C-AC90-0DA3E383FA97

Q21195217-579502E4-C32D-4948-AFB7-ECECDF7EE22F

Q21195217-5D876A73-0DE5-45F9-AAA2-75DCE76A228A

Q21195217-6543A12E-6B37-44B5-A46C-4F27DD0667E1

Q21195217-815FBFAE-2781-4AFB-99A0-4617112FAC17

Q21195217-86A50066-F901-4D1D-AA7B-CC888DF3C8A8

Q21195217-88E99A23-E424-42A1-9AE2-87BCAA9650FE

Q21195217-8B83143F-4AD0-4028-AAF3-57CC0C0E4FA1

P2888

Q21195217-0C2CA0CD-EFE1-4DF5-A623-99C3540C24D0

P304

Q21195217-AB9B1567-A40F-4367-A72D-910D0317320D

P31

Q21195217-2E5C5F68-4E69-40F4-B0AC-CE988F4BC76C

P3181

Q21195217-A482E764-8B36-42AD-87AD-22E06DDAED39

P356

Q21195217-EE8C2A6B-8222-41A5-AADC-01A5514B2C12

P407

Q21195217-AACF4F20-261C-429E-835C-5236F08F7888

P433

Q21195217-5926F409-734D-40AA-9E3A-182006D8CFEB

P478

Q21195217-0D479CC5-4660-4342-A470-BB55FE66877A

P50

Q21195217-3D688675-57B2-4ACC-B8C5-CD607D3A82EB

Q21195217-4B60A539-D22D-48DC-9143-10D363354458

Q21195217-915582C6-ACBE-4444-B3D1-A11D6CD99003

Q21195217-946E21C0-2E20-4634-91F7-AAB853F80BBC

Q21195217-EDEC3781-F5B6-47C1-A179-E96FC4FD959D

P577

Q21195217-54DBA82F-D7F2-4787-AA40-46E4D64907BD

P5875

Q21195217-80C3E09D-355B-42F8-B854-6CE33826DD74

P6179

Q21195217-A4D8E769-E233-4E4C-A72F-DDDF20EB1AA9

P698

Q21195217-C3ED73FC-8998-4FD5-920B-F56670140470

P932

Q21195217-4F3ACB0F-072F-44F6-9E66-C797E30E4B9E

P3181

P356

P1433

Breast Cancer Research

P1476

The ubiquitin-like molecule in ...... marker in human breast cancer

@en

P2093

Amjad Naami

http://www.w3.org/2001/XMLSchema#string

Arndt Hartmann

http://www.w3.org/2001/XMLSchema#string

Arno Dimmler

http://www.w3.org/2001/XMLSchema#string

Erik Noetzel

http://www.w3.org/2001/XMLSchema#string

Glen Kristiansen

http://www.w3.org/2001/XMLSchema#string

Michael F Press

http://www.w3.org/2001/XMLSchema#string

Nuran Bektas

http://www.w3.org/2001/XMLSchema#string

P2860

A model for p53-induced apoptosis

Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways

High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction.

Proteomic identification of proteins conjugated to ISG15 in mouse and human cells.

Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays

Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer

Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays

Pre-mRNA splicing: awash in a sea of proteins

P2888

P304

R58

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3593588

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/BCR2117

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Ruth Knüchel-Clarke

Peter A. Fasching

Matthias W. Beckmann

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51402690

http://www.w3.org/2001/XMLSchema#string

P6179

1037340556

http://www.w3.org/2001/XMLSchema#string

P698

18627608

http://www.w3.org/2001/XMLSchema#string

P932

2575531

http://www.w3.org/2001/XMLSchema#string